| NCT ID | NCT06548061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dartmouth-Hitchcock Medical Center |
| Condition | Spinal Metastases |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-05-16 |
| Primary Completion | 2029-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2024-05-16 with a primary completion date of 2029-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.
Eligibility Criteria
Inclusion Criteria: 1. Histology confirmed spinal tumor involving the T2-T12 spine segments. 2. Indication for spine stereotactic radiosurgery or palliative intervention. 3. Normal neurologic exam at the time of presentation (Frankel grade E). Exclusion Criteria: 1. Contraindication to MRI 2. ANY neurologic deficit 3. Tumor spanning more than 3 consecutive vertebral segments 4. Contraindication to general anesthesia 5. Pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06548061 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Metastases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06548061 currently recruiting?
Yes, NCT06548061 is actively recruiting participants. Contact the research team at lauren.j.sinks@hitchcock.org for enrollment information.
Where is the NCT06548061 trial being conducted?
This trial is being conducted at Lebanon, United States.
Who is sponsoring the NCT06548061 clinical trial?
NCT06548061 is sponsored by Dartmouth-Hitchcock Medical Center. The trial plans to enroll 25 participants.